sameAs
P108
Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaA Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian CancerA Study Evaluating the Efficacy and Safety of Tislelizumab Versus Chemotherapy in Advanced Non-Squamous NSCLCA Phase 3 Randomized, Double-blind, Placebo-controlled, Multicenter Trial of Maintenance Treatment With BGB-290 Versus Placebo in Patients With Platinum-sensitive Recurrent Ovarian CancerA Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast CancerA Study Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer.Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal CancerA Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast CancerPhase 3 Study of BGB-A317 Versus Sorafenib in Patients With Unresectable HCCStudy of BGB-A317 in Patients With Previously Treated Unresectable HCC
P6153
Q62030726-82FAD3E1-E52C-456A-B840-AA6BFBE784F9Q62042285-5109C863-9904-4CCE-A09B-ACC6DBF4A91FQ62062171-CCD372C2-7949-4711-B9FA-DA26470450A5Q62816973-05A21B10-8AF6-4B6B-95BE-594C2ACAC0C6Q63335890-36E9B819-A7F1-44BB-9AF5-BA95C6BDFC44Q63394796-8FD839BE-DFB4-4A19-867E-F4809C2E19F2Q63397028-8D11FAAF-3091-49FA-991F-BB10D91F4D60Q63399284-3E8A9A22-BF99-434F-AE78-EB8504F25DF5Q63402028-C617A5C2-2AFB-4DB8-8021-F04583B4E0E8Q63403773-6351B314-4104-4903-B254-EB598D43770A
P6153
description
griya sakit
@jv
healthcare organization in Wuhan, China
@en
rumah sakik
@min
rumah sakit di Republik Rakyat Tiongkok
@id
rumoh sakét
@ace
مستشفى في ووهان، الصين
@ar
name
Hubei Cancer Hospital
@en
湖北省肿瘤医院
@zh
type
label
Hubei Cancer Hospital
@en
湖北省肿瘤医院
@zh
altLabel
HBCH
@en
prefLabel
Hubei Cancer Hospital
@en
湖北省肿瘤医院
@zh
P131
P213
0000 0004 1758 2326
P2427
grid.413606.6
P3500
P571
1973-01-01T00:00:00Z
P625
Point (114.365862 30.501756)